Immunostep, S.L.
PrivateLast Round
Secondary
May 25, 2016
Company Overview
Immunostep, S.L. operates in Healthcare & Life Sciences and is based in Salamanca. It was founded in 2000.
Immunostep, S.L. is a biotechnology company that develops and manufactures flow cytometry reagents, diagnostic kits, and antibodies for clinical research and diagnostic applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Immunostep, S.L. Comparables
Compare Immunostep, S.L. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SIRION Biotech | 76% | |
| Neomend | 76% | |
| Miltenyi Biotec | 71% |
For institutional investors. Book with your work email.
Immunostep, S.L. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Immunostep, S.L. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Unirisco Galicia | VC Round |
| Uninvest | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 17, 2026
Grew 18% QoQ, from 17 to 20 employees.
- Dec 25, 2025
Grew 20% QoQ, from 15 to 18 employees.
For institutional investors. Book with your work email.
Immunostep, S.L. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Immunostep, S.L.'s valuation, stock price, and market status.
Is Immunostep, S.L. a public or private company?
Immunostep, S.L. is a private company.
What is the current stock price of Immunostep, S.L.?
Immunostep, S.L. is a private company, so its shares have no public market price. Caplight tracks Immunostep, S.L.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Immunostep, S.L. worth (valuation)?
Valuation information for Immunostep, S.L. is not publicly available.
Can I buy Immunostep, S.L. stock?
Immunostep, S.L. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Immunostep, S.L.'s last funding round?
Immunostep, S.L.'s most recent funding round was Secondary on May 25, 2016.
Who are the main investors in Immunostep, S.L.?
Key investors in Immunostep, S.L. include Uninvest.
Will Immunostep, S.L. IPO soon?
No public IPO plans have been announced for Immunostep, S.L..
How can I track Immunostep, S.L. secondary market activity?
Caplight tracks bids, offers, and trades in Immunostep, S.L.'s shares on secondary markets.